Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Equity (2016 - 2025)

Historic Return on Equity for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.18%.

  • Vanda Pharmaceuticals' Return on Equity fell 1500.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.03% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Return on Equity of 0.18% as of Q3 2025, which was down 1500.0% from 0.13% recorded in Q2 2025.
  • Vanda Pharmaceuticals' Return on Equity's 5-year high stood at 0.07% during Q3 2021, with a 5-year trough of 0.18% in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' median Return on Equity value was 0.01% (recorded in 2022), while the average stood at 0.0%.
  • Data for Vanda Pharmaceuticals' Return on Equity shows a peak YoY increase of 300bps (in 2021) and a maximum YoY decrease of -2100bps (in 2021) over the last 5 years.
  • Vanda Pharmaceuticals' Return on Equity (Quarter) stood at 0.07% in 2021, then plummeted by -82bps to 0.01% in 2022, then tumbled by -62bps to 0.0% in 2023, then tumbled by -859bps to 0.04% in 2024, then plummeted by -405bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.13% for Q2 2025, and 0.08% during Q1 2025.